0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Neurology |

This Month in Archives of Neurology FREE

Arch Neurol. 2007;64(10):1383-1384. doi:10.1001/archneur.64.10.1383.
Text Size: A A A
Published online

TDP-43 AND NEURODEGENERATIVE DISEASE

To facilitate understanding of a group of disorders collectively known as TDP-43 proteinopathies, Neumann and colleagues review advances made since it was shown that TAR-DNA binding protein 43 (TDP-43) is the major disease protein that links frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without motor neuron disease to amyotrophic lateral sclerosis. It is an important new insight into the molecular basis of these disorders and offers new insights into disease causation.

THE MINIMALLY CONSCIOUS STATE

Fins et al propose 2 models characterizing minimal conscious state (MCS) epidemiology. A severity model integrates diagnostic and severity of injury codes and a venue model that tracks patient migration after hospital discharge. The epidemiology of MCS is reviewed.

DNA GENE VACCINATION FOR MULTIPLE SCLEROSIS

A new DNA gene vaccine encoded for full-length human myelin basic protein was studied by Bar-Or and colleagues. They assessed the safety and immune modulations of the vaccine in patients with multiple sclerosis. They found that it is safe and well tolerated and provided favorable trends on brain magnetic resonance imaging and produced beneficial antigen-specific immune changes. These immune changes consisted of a marked decrease in proliferation of interferon γ–producing myelin-reactive CD4+ T cells and a reduction in titers of myelin-specific autoantibodies from cerebral spinal fluid. Editorial perspective is provided by Olaf Stüve, MD, PhD; Todd N. Eagar, PhD; Elliot M. Frohman, MD, PhD; and Petra D. Cravens, PhD.

FULMINANT DEMYELINATING DISEASE

In a retrospective case study, de Seze and colleagues analyzed 60 patients with acute demyelinating encephalomyelitis (ADEM) for risk of evolution to multiple sclerosis (MS). They concluded that the presence of any 2 of 3 criteria could be used to differentiate ADEM from MS: atypical clinical symptoms for MS, absence of oligoclonal bands, and gray matter involvement.

CORTICAL INFLAMMATORY LESIONS IN MULTIPLE SCLEROSIS

Calabrese et al used double inversion recovery sequence magnetic resonance imaging to determine frequency, time of appearance, and clinical relevance of intracortical lesions (ICLs) in patients with multiple sclerosis (MS). They indicate that ICLs assist in defining MS clinical heterogeneity and prognosis (Figure).

Place holder to copy figure label and caption
Figure

Mean numbers of intracortical lesions (ICLs) in all patients included in the study. First, second (median), and third quartiles are used for the box construction, whereas 1.5 × (quartile 3−quartile 1) is used for the whiskers. Points outside the whiskers are considered outliers (cases with values between 1.5 and 3 box lengths from the upper or lower edge of the box). Asterisks indicate extreme cases (cases with values more than 3 box lengths from the upper or lower edge of the box). CIS indicates clinically isolated syndrome; RRMS, relapsing-remitting multiple sclerosis; and SPMS, secondary progressive multiple sclerosis.

Graphic Jump Location

PROGRANULIN IN A FAMILY AND DIAGNOSES OF ALZHEIMER AND PARKINSON DISEASE

Brouwers et al assessed whether genetic variability in progranulin (PGRN) associated with frontotemporal lobar degeneration also contributed to other common degenerative brain disease, such as Alzheimer disease (AD) or Parkinson disease (PD). They report that their mutation data indicated that null mutations are very rare in patients with AD and PD and likely result from etiological heterogeneity rather than PGRN haploinsufficiency per se.

RISK OF COGNITIVE IMPAIRMENT OR DEMENTIA IN RELATIVES OF PATIENTS WITH PARKINSON DISEASE

Rocca et al found that cognitive impairment or dementia may share familial susceptibility factors with Parkinson disease.

IMAGING THE AΒ-RELATED NEUROTOXICITY OF ALZHEIMER DISEASE

Moreno and colleagues show that the neurotoxicity related to Aβ peptide can be captured in vivo by functional imaging and suggest hippocampal subregions most vulnerable to its toxic effects.

THREE-DIMENSIONAL GRAY MATTER ATROPHY MAPPING IN MILD COGNITIVE IMPAIRMENT AND MILD ALZHEIMER DISEASE

With magnetic resonance imaging and an advanced 3-dimensional cortical mapping technique, Apostolova and colleagues show striking cortical differences between mild Alzheimer disease and amnestic mild cognitive impairment.

PHARYNGEAL-CERVICAL-BRACHIA VARIANT OF GUILLAIN-BARRÉ SYNDROME

Nagashima and colleagues describe the clinical features of pharyngeal-cervical-brachial weakness.

REAL-WORLD REPLICATION OF RANDOMIZED CONTROLLED TRIAL RESULTS FOR CAROTID ENDARTERECTOMY

Feasby et al report that randomized clinical trials for carotid endarterectomy can be achieved in the “real world.” However, some hospitals exceed the maximum suggested adverse event rates, which highlights the need for continuous outcome monitoring and associate quality improvement efforts to ensure that all providers and institutions involved are achieving desired outcomes.

TDP-43 PATHOLOGY AND FRONTOTEMPORAL LOBAR DEGENERATION

Grossman and colleagues studied demographic, clinical, and neuropsychological features associated with subtypes of frontotemporal lobar degeneration (FTLD-U) with TDP-43 inclusions. They found that there are significantly different clinical and neuropsychological patterns of impairment in FTLD-U subtypes. Distinct TDP-43 profiles impact clinical phenotypes differentially in patients with FTLD-U pathology.

ASIAN ORIGIN FOR THE WORLDWIDE-SPREAD MUTATIONAL EVENT IN MACHADO-JOSEPH DISEASE

Martins et al found that the worldwide-spread mutation of Machado-Joseph disease may have occurred in Asia, being later diffused throughout Europe with a founder effect accounting for its high prevalence in Portugal.

IMPORTANCE OF LOW-RANGE CAG EXPANSION AND CAA INTERRUPTION IN SCA2 PARKINSONISM

Kim et al conclude that SCA2 is one of the causes of Parkinson disease and the Parkinson variant of multiple system atrophy. CAG repeats were in the low-range expansion and interrupted by CAA in all patients.

REDUCED HIPPOCAMPAL FUNCTIONAL CONNECTIVITY IN ALZHEIMER DISEASE

Allen et al determined whether functional connectivity of the hippocampus is reduced in Alzheimer disease (AD). Functional connectivity magnetic resonance imaging was used to investigate coherence in the magnetic resonance signal between hippocampus and all other regions of the brain. Their findings suggest a functional disconnection between hippocampus and other brain regions in AD.

Figures

Place holder to copy figure label and caption
Figure

Mean numbers of intracortical lesions (ICLs) in all patients included in the study. First, second (median), and third quartiles are used for the box construction, whereas 1.5 × (quartile 3−quartile 1) is used for the whiskers. Points outside the whiskers are considered outliers (cases with values between 1.5 and 3 box lengths from the upper or lower edge of the box). Asterisks indicate extreme cases (cases with values more than 3 box lengths from the upper or lower edge of the box). CIS indicates clinically isolated syndrome; RRMS, relapsing-remitting multiple sclerosis; and SPMS, secondary progressive multiple sclerosis.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

227 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs